D'Amelio A. Frank's Insider Trades & SAST Disclosures
D'Amelio A. Frank's most recent trade in Zoetis Inc - Ordinary Shares - Class A was a trade of 1,596 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern D'Amelio A. Frank.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 1,596 | 1,596 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2025 | 1,225 | 9,857 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,225 | 0 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 8,632 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 0 | - | - | Restricted Stock Unit | |
| Humana Inc. | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 26,060 | - | - | Restricted Stock Units | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 14,068 | 14,068 | - | - | Restricted Stock Units | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 17,389 | 17,389 (0%) | 0% | 0 | Common Stock | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 17,389 | 0 | - | - | Restricted Stock Units | |
| Zoetis Inc - Ordinary Shar... | A. Frank D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2024 | 1,463 | 7,316 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank D'Amelio A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,463 | 1,212 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | D'Amelio A. Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 0 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | D'Amelio A. Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 5,853 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | A. Frank D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,223 | 1,223 | - | - | Restricted Stock Unit | |
| Humana Inc. | D'Amelio Frank A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 430 | 430 | - | - | Restricted Stock Units | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 17,010 | 17,010 | - | - | Restricted Stock Units | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 3,444 | 0 | - | - | Restricted Stock Units | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 3,444 | 3,444 (0%) | 0% | 0 | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,626 | 2,651 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 1,626 | 4,321 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 1,480 | 1,480 | - | - | Restricted Stock Unit | |
| Hewlett Packard Enterprise Co | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 3,444 | 3,444 | - | - | Restricted Stock Units | |
| Humana Inc. | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 127,160 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.60 per share. | 26 Feb 2022 | 127,160 | 649,918 (0%) | 0% | 25.6 | 3,255,296 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.64 per share. | 26 Feb 2022 | 59,370 | 555,941 (0%) | 0% | 50.6 | 3,006,497 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.72 per share. | 26 Feb 2022 | 34,607 | 615,311 (0%) | 0% | 47.7 | 1,651,446 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 153,789 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2022 | 153,789 | 636,977 (0%) | 0% | 27.3 | 4,204,591 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 126,794 | 126,794 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 111,516 | 111,516 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 23 Feb 2022 | 76,120 | 522,758 (0%) | 0% | 51.3 | 3,903,434 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.87 per share. | 23 Feb 2022 | 38,099 | 598,878 (0%) | 0% | 46.9 | 1,785,700 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 2,673 | 2,673 | - | - | Deferred Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 2,673 | 4,244 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 1,192 | 6,917 | - | - | Restricted Stock Unit | |
| Humana Inc. | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 412 | 412 | - | - | Restricted Stock Units | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 152,785 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. | 27 Feb 2021 | 152,785 | 607,441 (0%) | 0% | 22.4 | 3,414,745 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.64 per share. | 27 Feb 2021 | 96,872 | 483,188 (0%) | 0% | 34.6 | 3,355,646 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.49 per share. | 27 Feb 2021 | 27,381 | 580,060 (0%) | 0% | 33.5 | 916,990 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 210,697 | 210,697 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 182,050 | 182,050 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2021 | 163,334 | 588,584 (0%) | 0% | 22.9 | 3,738,715 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 163,334 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 25 Feb 2021 | 105,707 | 454,656 (0%) | 0% | 34.8 | 3,674,375 | Common Stock |
| Pfizer Inc. | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.82 per share. | 25 Feb 2021 | 28,221 | 560,363 (0%) | 0% | 33.8 | 954,434 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2021 | 2,779 | 15,695 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2021 | 2,779 | 5,694 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Other type of transaction at price $ 166.71 per share. | 13 Feb 2021 | 887 | 14,808 (0%) | 0% | 166.7 | 147,872 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 1,431 | 8,473 | - | - | Restricted Stock Unit | |
| Humana Inc. | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 403 | 403 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges